March 18, 2021 -- MilliporeSigma is adding a single-use assembly production unit to its facility in Molsheim, France.
The new unit represents an investment of $30 million and will allow the company to boost its capacity to produce COVID-19 vaccines and other therapies, it said. The new unit will add more than 350 new jobs and 18,300 sq ft of space. It will produce Mobius single-use assemblies, and will be in operation by the end of the year, according to the firm.
MilliporeSigma is accelerating its European expansion plans for single-use assembly technology, which is used for the production of Covid-19 vaccines and other lifesaving therapies. Image courtesy of MilliporeSigma.
MilliporeSigma is expanding its capacity at its facilities in Darmstadt, Germany; Cork, Ireland; Buchs, Switzerland; Carlsbad, CA; Madison, WI; Jaffrey, NH; and Danvers, MA. At the Danvers site, the company is working to double single-use production capacity by the end of 2021, it said.
Copyright © 2021 scienceboard.net